Mavis Obeng‐Kusi

Merck & Co., Inc., Rahway, NJ, USA (United States)

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Network meta-analysis of second line and beyond treatment options in metastatic clear cell renal cell carcinoma”.

Network meta-analysis of second line and beyond treatment options in metastatic clear cell renal cell carcinoma

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2023.12.002

N/A

0DataRank · unranked

5 citations

Jordyn Kreutzfeldt, Ricardo J. Estrada-Mendizábal, Briana Choi, Ivo Abraham, Alejandro Recio‐Boiles +1 more